74387. Group Leader
Session: Poster Discussion Round: Antimicrobial Resistance
Thursday, October 4, 2018: 12:30 PM
Room: S Poster Hall
C. Buddy Creech, MD, MPH, FPIDS, Vanderbilt Vaccine Research Program, Vanderbilt University School of Medicine, Nashville, TN

Dr. Creech serves as Director of the Vanderbilt Vaccine Research Program and Associate Professor of Pediatric Infectious Diseases at Vanderbilt University School of Medicine. His research interests are in staphylococcal immunopathogenesis, staphylococcal colonization, and vaccine preventable diseases, including S. aureus, pertussis, and influenza. He currently serves as principal investigator of the Vanderbilt Vaccine and Treatment Evaluation Unit.


Disclosures:

C. B. Creech, Pfizer: Grant Investigator , Research grant . Novartis: Grant Investigator , Research grant . GSK: Consultant , Consulting fee . Premier Healthcare: Scientific Advisor , Consulting fee . Merck: Grant Investigator , Research grant . UpToDate: Consultant , Licensing agreement or royalty .

Previous Abstract | Next Abstract >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.